April 24, 2015 – The papers were selected by the Clinical Research Forum from a pool of more than 50 nominations from 30 research and academic health centers.
The Clinical Research Forum has named two manuscripts with DCRI involvement to their list of 10 Most Outstanding Research papers for 2014.
The ten winning papers were chosen based on their degree of innovation from a pool of more than 50 nominations from 30 research and academic health centers nationwide, including Duke, Georgetown, the University of Pennsylvania, and others. The manuscripts were considered those that represent the best-in-field work with the promise to lead to advancements in medicine that will change patients’ lives.
The awards were presented during the Forum’s annual meeting in Washington, D.C.
The winning manuscripts recognized during this fourth annual award ceremony were:
- Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative, published in JAMA. DCRI authors included Adrian Hernandez, Ying Xian, Xin Zhao, and Eric Peterson.
- Antidepressant Use in Pregnancy and the Risk of Cardiac Defects, published in the New England Journal of Medicine. Soko Setoguchi-Iwata was the DCRI team member.
“I applaud the researchers recognized today for their groundbreaking clinical research that will advance new treatments to reduce suffering and bring hope to millions of people,” said NIH Director Francis Collins. “And I’m especially proud that NIH funding makes these advances possible.”
The Clinical Research Forum was formed in 1996 to discuss the unique and complex challenges to clinical research in academic health centers. Over the past decade it has convened leaders at the highest levels in academic institutions, the pharmaceutical industry, information technology industry, and government to draw upon their perspectives in addressing the challenges and opportunities facing the clinical research enterprise.